NASHUA, N.H., Oct. 27, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on November 10, 2022.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
| Conference Call | ||
| Thursday, November 10, 2022 at 4:30 PM ET | ||
| Domestic: | 888-506-0062 | |
| International: | 973-528-0011 | |
| Conference ID: | 393244 | |
| Webcast: | https://www.webcaster4.com/Webcast/Page/2879/46603 | |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
[email protected]
Investor Inquiries:
iCAD Investor Relations
[email protected]
